Stockreport

Gain Therapeutics' CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update [Yahoo! Finance]

Gain Therapeutics, Inc.  (GANX) 
PDF the discovery and development of allosteric small molecule therapies, today releases the following letter to stockholders from its President and Chief Executive Officer [Read more]